Sachpekidis et al. showed that a [68Ga]Ga-PSMA PET/CT study had a 96% and 71% detection rate in assessing the severity of the disease in staging and recurrent prostate cancer, respectively [5,6]. The gene discussed is FOLH1; the disease is prostate carcinoma.